Friday, January 30, 2026

Hyundai, Kia Face a $3.75B Hit if U.S. Tariffs Return to 25%: What Should Seoul Do Next?

U.S. tariffs on Korean cars may rise to 25%, threatening Hyundai and Kia's profits with potential losses exceeding $3.75 billion.

Oil of the 21st Century: Why China’s Control Over Rare Earths Is More Dangerous Than Middle East Oil

China dominates the rare earth market, leveraging its resources in trade disputes with the U.S., raising environmental concerns.

North Korea Promotes Women’s Rights as Propaganda Tool, Analysts Say

North Korea's Gender Equality Law promotes women's rights, yet analysts view it as propaganda rather than genuine progress.

Tag: Korea

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationschina

A Man Was Falsely Diagnosed With HIV—and Then Denied a $1,050 Refund After Doctors Admitted They Were Wrong

A man misdiagnosed with HIV before shoulder surgery faced distress and denial of a refund, exposing issues in South Korea's medical system.

Hunger Strike Ends in Hospitalization: What Jang Dong-hyuk’s Collapse Signals for South Korea’s Political Standoff

Jang Dong Hyuk, leader of the People Power Party, hospitalized after hunger strike; doctors prioritize cardiac tests amid health concerns.

Humanoid Robots in Logistics: Will CJ Logistics and Lotte’s AI Innovations Transform the Industry?

South Korean logistics firms are testing humanoid robots to enhance efficiency, aiming to assist in complex tasks traditionally done by humans.

Data Control Wars: Orchestra Group Unveils a Sovereign AI Cloud That Ditches Public Providers

Orchestra Group launches a Sovereign AI Cloud Data Center to enhance data sovereignty and control over AI infrastructure for organizations.

At CES 2026, Korean Leaders Call for a Balanced AI Strategy Amid U.S.–China Tech Rivalry

At CES 2026, Korean leaders emphasized a balanced AI strategy to leverage manufacturing strengths amidst U.S.-China competition.

2023 Cancer Statistics: Prostate Cancer Surges to Top Spot Among Men in Korea

Prostate cancer is now the most common cancer in South Korean men, reflecting demographic shifts and improved survival rates.

2025’s Drug Price Revolution: What Asian Pharma Firms Need to Know About MFN Policies

Trump's second term sees U.S. drug pricing reforms and supply chain shifts, prompting South Korean firms to seize new opportunities.

Korean Innovator Wins CNCF Community Awards 2025: What This Means for Open Source in Asia

Son Seok-ho becomes the first Korean to win the CNCF Community Awards 2025, recognizing his impactful contributions to open-source projects.

SK Telecom Integrates A.Dot Auto Into Renault Korea’s Filante: Expanding AI’s Role in the Connected Car

SK Telecom integrates A.Dot Auto into Renault Korea's Filante, enhancing vehicle AI with advanced voice control and contextual awareness.

Amid Rising Drug Resistance, Korea Begins DOMINO Trial to Reassess First-Line Treatment for Pediatric Mycoplasma

The DOMINO trial will assess treatments for pediatric Mycoplasma pneumonia, addressing rising macrolide resistance in Korea.

2026: South Korea’s Advanced Regenerative Medicine R&D Investment Expands – What You Need to Know!

The Ministry of Health and Welfare aims to boost investments in advanced regenerative medicine R&D and improve research infrastructure in South Korea.

Why Korean Robots Are Winning the AI Battle at CES 2026: A Deep Dive into Atlas and CLOiD

CES 2026 showcased China's dominance in robotics, while South Korean firms excelled in AI and display technology, impressing attendees.

HK inno.N’s New Drug K-CAB Applies for U.S. FDA Approval: How Innovative Is the P-CAB Therapy?

HK inno.N's K-Cap for GERD has entered the U.S. approval process, showing superior results in clinical trials over existing treatments.

How Neurophet AQUA is Transforming Dementia Diagnosis in South Korea: Key MOU Insights

Neurophet partners with Eisai Korea to enhance dementia screening and diagnostics using AI-based software, Neurophet AQUA.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.